Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Amino Acids and Derivatives >  Tyrosine derivatives >  AG 490

AG 490

Basic information Safety Supplier Related

AG 490 Basic information

Product Name:
AG 490
Synonyms:
  • AG 490;TYRPHOSTIN AG 490;AG490;ZINC02557947;AG-490 (TYRPHOSTIN B42)
  • CS-316
  • AG 490 - CAS 133550-30-8 - Calbiochem
  • 2-CYANO-3-[3,4-DIHYDROXYPHENYL]-N-[PHENYLMETHYL]-2-PROPENAMIDE
  • N-BENZYL-3,4-DIHYDROXY-ALPHA-CYANOCINNAMIDE
  • N-BENZYL-3,4-DIHYDROXY-BENZYLIDENECYANOACETAMIDE
  • TYROPHOSTIN AG490
  • TYRPHOSTIN AG 490
CAS:
133550-30-8
MF:
C17H14N2O3
MW:
294.3
Product Categories:
  • Intracellular Signaling
  • Inhibitors
  • Protein Kinase
  • Inhibitor
Mol File:
133550-30-8.mol
More
Less

AG 490 Chemical Properties

Melting point:
215°C(lit.)
Boiling point:
615.2±55.0 °C(Predicted)
Density 
1.337
storage temp. 
-20°C
solubility 
ethanol: 5 mg/mL
form 
solid
pka
8.75±0.10(Predicted)
color 
yellow
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO, DMF, or ethanol may be stored at -20°C for up to 1 month.
InChIKey
TUCIOBMMDDOEMM-ZSOIEALJSA-N
More
Less

Safety Information

Hazard Codes 
Xi,N,T
Risk Statements 
36/37/38-50-25
Safety Statements 
26-36-61-45
RIDADR 
UN2811 - class 6.1 - PG 3 - EHS - Toxic solids, organic, n.o.s., HI: all
WGK Germany 
1
RTECS 
UC6316197
HazardClass 
6.1
PackingGroup 
III
HS Code 
29269090

MSDS

More
Less

AG 490 Usage And Synthesis

Description

AG-490 (133550-30-8) is a potent inhibitor of the JAK2 tyrosine kinase. In acute lymphoblastic leukemia (ALL) cells, which abundantly express JAK-2, AG-490 dose-dependently blocked cell growth, induced apoptosis and inhibited DNA synthesis. Blocks the growth of all pre-B ALL cells with no effect on normal B or T cells. Does not significantly inhibit other kinases such as Lck, Lyn, Btk, Syk and Src. Reduces liver injury in LPS-induced shock.3 AG-490 is a useful tool for exploring the role of JAK2/STAT3 pathway in physiologic processes.4

Uses

AG 490 is a potent epidermal growth factor receptor kinase autophosphorylation inhibitor with an IC50 of 100 nM and 56.8 μM for EGFR and JAK, respectively.

Uses

Tyrphostin AG has been used to block IL-6 cytokine signaling to study its effects on glial cell reactivity5. AG 490 has also been used as a JAK2 inhibitor in human umbilical vein endothelial cells6.

Definition

ChEBI: Tyrphostin B42 is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoic acid with the amino group of benzylamine. It has a role as an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, an antioxidant, a STAT3 inhibitor, an anti-inflammatory agent, an apoptosis inducer and a geroprotector. It is an enamide, a monocarboxylic acid amide, a nitrile, a member of catechols and a secondary carboxamide.

Biological Activity

Selective inhibitor of EGF receptor tyrosine kinase (IC 50 values are 2 and 13.5 μ M for EGFR and ErbB2 respectively). Inhibitor of JAK2, JAK3/STAT, JAK3/AP-1 and JAK3/MAPK pathways and potently inhibits cytokine-independent cell growth in vitro and tumor cell invasion in vivo .

Biochem/physiol Actions

Jak-2 protein tyrosine kinase (PTK) inhibitor. Inhibits interleukin 2 (IL-2) driven mitogenesis and triggers apoptosis of tumor cells in Sezary syndrome, a leukemic variant of cutaneous T cell lymphoma.

storage

Room temperature

References

References/Citations 1) Wang et al. (1999), JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response; J. Immunol. 162 3897 2) Meydan et al. (1996), Inhibition of acute lymphoblastic leukaemia by Jak-2 inhibitor; Nature, 379 645 3) Gyurkovska and Ivanovaska (2015), Tyrosine kinase inhibitor tyrphostin AG490 reduces liver injury in LPS-induced shock; Eur. J. Pharmacol., 751 118 4) Wu et al. (2015), ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(+2) overload and contractile dysfunction via the JAK2/STAT3 pathway; J. Mol. Cell. Cardiol., 81 150

AG 490Supplier

Beijing Jin Ming Biotechnology Co., Ltd. Gold
Tel
010-60605840 18892239720
Email
psaitong@jm-bio.com
Changzhou Chenhong Biotechnology Co., Ltd. Gold
Tel
0519-85788828 13775037613
Email
sales@chemrenpharm.com
Angel Pharmatech, Ltd. Gold
Tel
17317130613
Email
3358272972@qq.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com